AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteXanomeline oxalate is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).
More Information Supplier PageXanomeline oxalate is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).
More Information Supplier PageXanomeline oxalate is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).
More Information Supplier PageXanthatin, a xanthanolide sesquiterpenoid exhibiting potent antibacterial activity against MRSA.
More Information Supplier PageXanthatin, a xanthanolide sesquiterpenoid exhibiting potent antibacterial activity against MRSA.
More Information Supplier PageXanthatin, a xanthanolide sesquiterpenoid exhibiting potent antibacterial activity against MRSA.
More Information Supplier PageXanthone is an organic compound. It can be prepared by the heating of phenyl salicylate. In 1939, xanthone was introduced as an insecticide and it currently finds uses as ovicide for codling moth eggs and as a larvicide. Xanthone is also used in the preparation of xanthydrol, which is used in the determination of urea […]
More Information Supplier PageXanthotoxol is a furanocoumarin. It is one of the major active ingredients in Cnidium monnieri.
More Information Supplier PageXanthotoxol is a furanocoumarin. It is one of the major active ingredients in Cnidium monnieri.
More Information Supplier PageXanthotoxol is a furanocoumarin. It is one of the major active ingredients in Cnidium monnieri.
More Information Supplier PageXAV 939 is a TNKS inhibitor (IC50 values are 0.011 and 0.004 ??M for TNKS1 and TNKS2 respectively).
More Information Supplier PageXAV 939 is a TNKS inhibitor (IC50 values are 0.011 and 0.004 ??M for TNKS1 and TNKS2 respectively).
More Information Supplier PageXAV 939 is a TNKS inhibitor (IC50 values are 0.011 and 0.004 ??M for TNKS1 and TNKS2 respectively).
More Information Supplier PageXAV 939 is a TNKS inhibitor (IC50 values are 0.011 and 0.004 ??M for TNKS1 and TNKS2 respectively).
More Information Supplier PageXAV 939 is a TNKS inhibitor (IC50 values are 0.011 and 0.004 ??M for TNKS1 and TNKS2 respectively).
More Information Supplier PageXL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases.
More Information Supplier PageXL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases.
More Information Supplier PageXL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases.
More Information Supplier PageXL228 is a protein kinase inhibitor targeting IGF1R, the AURORA kinases, FGFR1-3, ABL and SRC family kinases. XL228 is an Aurora A inhibitor (IC50, f3 nmol/L) that has shown potent biochemical activity against ABL1 (Ki, 5 nmol/L), as well as the BCR-ABL1 T315I (Ki, 1.4 nmol/L) kinases.
More Information Supplier PageXL228 is a protein kinase inhibitor targeting IGF1R, the AURORA kinases, FGFR1-3, ABL and SRC family kinases. XL228 is an Aurora A inhibitor (IC50, f3 nmol/L) that has shown potent biochemical activity against ABL1 (Ki, 5 nmol/L), as well as the BCR-ABL1 T315I (Ki, 1.4 nmol/L) kinases.
More Information Supplier PageXL228 is a protein kinase inhibitor targeting IGF1R, the AURORA kinases, FGFR1-3, ABL and SRC family kinases. XL228 is an Aurora A inhibitor (IC50, f3 nmol/L) that has shown potent biochemical activity against ABL1 (Ki, 5 nmol/L), as well as the BCR-ABL1 T315I (Ki, 1.4 nmol/L) kinases.
More Information Supplier PageXL228 is a protein kinase inhibitor targeting IGF1R, the AURORA kinases, FGFR1-3, ABL and SRC family kinases. XL228 is an Aurora A inhibitor (IC50, f3 nmol/L) that has shown potent biochemical activity against ABL1 (Ki, 5 nmol/L), as well as the BCR-ABL1 T315I (Ki, 1.4 nmol/L) kinases.
More Information Supplier PageXL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier PageXL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier PageXL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier PageXL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier PageXL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier PageXL019 is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity.
More Information Supplier PageXL019 is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity.
More Information Supplier PageXL019 is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity.
More Information Supplier PageXL019 is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity.
More Information Supplier PageXL019 is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity.
More Information Supplier PageXL147 is a potent, selective and orally bioavailable small molecule inhibitor of class I phosphatidylinositol 3 kinase (PI3K) with potential antineoplastic activity.
More Information Supplier PageXL147 is a potent, selective and orally bioavailable small molecule inhibitor of class I phosphatidylinositol 3 kinase (PI3K) with potential antineoplastic activity.
More Information Supplier PageXL147 is a potent, selective and orally bioavailable small molecule inhibitor of class I phosphatidylinositol 3 kinase (PI3K) with potential antineoplastic activity.
More Information Supplier PageXL147 is a potent, selective and orally bioavailable small molecule inhibitor of class I phosphatidylinositol 3 kinase (PI3K) with potential antineoplastic activity.
More Information Supplier PageXL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.
More Information Supplier PageXL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.
More Information Supplier PageXL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.
More Information Supplier Page
